All In Biotech

Drug Trial Radar · NCT00236990

An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate Gland

A Double-Blind, Randomized, Placebo-Controlled Trial of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Prostatitis

Last checked: Nov 19, 2026Latest source record: Jul 1, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 283 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

283

Actual

Start

Not stated

Primary completion

Not stated

Study completion Sep 2005

Sponsor

Sponsor type
Industry
Collaborators
Alza Corporation, DE, USA
First posted
Oct 12, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
Male only, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and effectiveness of ELMIRON® in the treatment of chronic non-bacterial inflammation of the prostate gland.

Conditions

  • Prostatitis

Interventions

  • pentosan polysulfate sodiumDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The change in total NIH-CPSI score from baseline to Week 12

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.